概括
当甲状腺激素被过氧化氧化时,甲状腺激素会失去活性,但囊可以恢复它. 这个过程是可逆的,取决于pH值.
科学领域:
- 生物化学 生物化学
- 内分泌学 在内分泌学.
- 蛋白质化学 蛋白质化学
背景情况:
- 副甲状腺激素 (PTH) 是一个关键的激素,调节和的平衡.
- 氧化应激可以影响蛋白质的结构和功能,包括激素.
- 了解PTH的稳定性和改变对于其治疗应用和生物研究至关重要.
研究的目的:
- 为了研究过氧化诱导的氧化对甲状腺上腺激素的生物活性的影响.
- 通过氧化使用氨酸来确定PTH无活化的可逆性.
- 探索pH对PTH氧化和还原过程的影响.
主要方法:
- 在受控条件下用过氧化来化甲状腺激素.
- 测定氧化PTH的生物活性.
- 用氨酸治疗氧化PTH和随后的活性评估.
- 在氧化和还原阶段的不同pH值.
主要成果:
- 副甲状腺激素在暴露于过氧化时经历了不活化.
- 生物活性的损失是部分或完全可逆的通过减少与氨酸.
- 氧化和还原的程度受到反应介质的pH值的显著影响.
结论:
- 副甲状腺激素容易受到过氧化的氧化失活.
- 氨酸可以有效地逆转PTH的氧化损伤,恢复其生物功能.
- pH是调节甲状腺激素稳定性和氧化还原依赖活性的关键因素.
相关概念视频
Radical Autoxidation
The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Phase I Oxidative Reactions: Overview
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Phase I Reactions: Reductive Reactions
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...


